- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03206996
Exposure Therapy for Auditory Sensitivity in Autism
June 14, 2019 updated by: University of Florida
Treatment for Auditory Hyper-Reactivity Behavior in Children With Autism Using Exposure and Response Prevention Principles
Auditory hyper-reactivity affects up to 66% of children with autism spectrum disorder (ASD) and has been linked to greater stress and anxiety for children and their families.
Exposure and Response Prevention (E/RP) is highly effective for reducing obsessive/compulsive behaviors in children with both OCD and ASD.
This study is the first to assess the feasibility and efficacy of E/RP for auditory sensory hyper-reactivity in ASD.
Study Overview
Status
Completed
Conditions
Detailed Description
Sensory processing difficulties have been well documented in children with Autism Spectrum Disorder (ASD).
In fact, "hyper- or hypo-reactivity to sensory input" has recently been added to the diagnostic criteria of this disorder.
Hyper-reactivity features are particularly disruptive to children's abilities to engage in everyday activities and pose a significant problem for patients and their families.
In children with high functioning pervasive developmental disorder, hyper-sensitivity is associated with symptoms of anxiety and depression.
For sensory processing difficulties, children with ASD are primarily referred to Occupational Therapy (OT) services for treatment.
These patients are also often seen by mental health professionals to address related disorders such as anxiety, ADHD and behavior problems.
Currently, there are no evidence based approaches for specifically addressing auditory hyper-reactivity in ASD.
Exposure and response prevention (E/RP), derived from systematic desensitization, is highly effective at reducing avoidance behaviors associated with phobias and obsessive and compulsive disorder (OCD).
In mental healthcare settings, ER/P has been shown to be effective for reducing compulsive behaviors in children with OCD and concurrent ASD.
E/RP has also been piloted for treating restricted, repetitive behaviors in ASD and demonstrates good feasibility.
E/RP may also be useful for reducing aversive responses to auditory stimuli in children with ASD.
Occupational Therapists (OT) are the primary service for providing treatment for sensory processing and arousal level modulation difficulties in children with ASD.
Thus, OTs are potentially well suited to provide an E/RP aimed at reducing sensory hyper-reactivity in ASD.
This study will investigate the feasibility and efficacy of utilizing an E/RP approach for treating auditory hyper-reactivity in ASD.
Study Type
Interventional
Enrollment (Actual)
5
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32611
- University of Florida
-
Gainesville, Florida, United States, 32606
- UF Health Child and Adolescent Psychiatry/Medical Psychology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 17 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria of children:
- autism spectrum disorders (ASD) diagnosis with symptoms of auditory hyper-sensitivity/reactivity.
- verbal communication skills for utilizing the Subjective Units of Distress (SUD) scale (no cut-off for IQ).
Exclusion Criteria of children
- behavioral diagnosis of Oppositional Defiant Disorder or Conduct Disorder
- history of child abuse that is related to sound sensitivity
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Child Interventional
A 12 week patient-centered modified E/RP protocol for up to 5 participants with ASD and auditory hyper-reactivity.
E/RP protocols will include face-to-face treatment sessions as well as the provision of home programs.
Treatment fidelity checklists will be utilized each session to ensure that each participant receive the same general protocol/treatment process
|
The therapist, child and family collaborate to set short and long term goals, develop the exposure hierarchy and Subjective Units of Distress (SUD) scale and design their "challenge" activities (i.e., exposures).
The exposure hierarchy lists activities in ascending order from minimal exposure/minimally difficult (e.g, toilet is not flushed and bathroom door is closed while child walks by) to maximum exposure/maximally difficult (e.g., toilet is flushed repeatedly while child is inside the stall with the door closed).
Treatment begins with exposure to activities on the lower end of the hierarchy, with adjustments as indicated, to present stimuli that provide a "just-right" level of difficulty as indicated by the participant's SUD level and therapists clinical judgment.
Participants communicate the level of difficulty using their individualized SUD scale.
Additionally, the child and family complete home exercises with exposures.
Other Names:
Child and caregiver receive education and training will be provided to improve the participant's self-awareness of his/her behavioral and emotional response to auditory stimuli, his/her ability to self-report anxiety/emotional response levels, as well as his/her ability to identify useful arousal level modulation/coping strategies.
During this phase, the child, caregiver and therapist will collaborate to identify the participant's Subjective Units of Distress Scale (SUD) from 0-10 with each level defined, particularly for what levels are tolerable or intolerable.
Parents will be provided with education on home programs to facilitate treatment gains.
Home programs will be designed specifically for each participant.
Parent education and home programs are provided either concurrently or after the exposure phase for the family to apply these methods to other settings.
Home programs can continue as a maintenance program after treatment has ended.
At the end of the treatment phase, the study team will conduct the following assessments for a third time: (1) the Sensory Profile, a clinical tool commonly used in OT to assess parent reports of sensory processing difficulties in children, (2) Parent Stress Index - 4 to evaluate stress related to parent-child interactions, and (3) the Modified Khalfa Hyper-acusis Questionnaire to assess the level of hyper-sensitivity to sound.
|
|
Experimental: Parental Interventional
A 12 week patient-centered modified E/RP protocol for up to 5 participants with ASD and auditory hyper-reactivity.
E/RP protocols will include face-to-face treatment sessions as well as the provision of home programs.
Treatment fidelity checklists will be utilized each session to ensure that each participant receive the same general protocol/treatment process
|
Parents will be provided with education on home programs to facilitate treatment gains.
Home programs will be designed specifically for each participant.
Parent education and home programs are provided either concurrently or after the exposure phase for the family to apply these methods to other settings.
Home programs can continue as a maintenance program after treatment has ended.
At the end of the treatment phase, the study team will conduct the following assessments for a third time: (1) the Sensory Profile, a clinical tool commonly used in OT to assess parent reports of sensory processing difficulties in children, (2) Parent Stress Index - 4 to evaluate stress related to parent-child interactions, and (3) the Modified Khalfa Hyper-acusis Questionnaire to assess the level of hyper-sensitivity to sound.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participant Subjective Unit of Distress (SUD) Level
Time Frame: weekly for approximately 20 weeks from intake to exit
|
The Subjective Unit of Distress (SUD) scale is a 0-10 scale used for the child and/or caregiver to report level of distress (i.e., pain, stress, anxiety, discomfort) before, during and/or after exposures to stimuli.
We expect that SUDS levels will decrease over time indicating improved ability to tolerate auditory stimuli.
|
weekly for approximately 20 weeks from intake to exit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Parent Stress Index
Time Frame: intake, end of baseline, end of treatment and exit (up to 4 times over approximately 20 weeks from intake to exit)
|
As an exploratory secondary outcome measure we will look for changes in scores on the parent Stress Index, a 36 item (5 point Likert scale response) parent report that is useful for identifying potential issues regarding the child's or parent's behavior and level of stress.
It is also useful for designing treatment plans, setting goals, follow-up and evaluating pre-/post- treatment outcomes.
|
intake, end of baseline, end of treatment and exit (up to 4 times over approximately 20 weeks from intake to exit)
|
|
Spence Child Anxiety Scale
Time Frame: intake, end of baseline, end of treatment and exit (up to 4 times over approximately 20 weeks from intake to exit)
|
As an exploratory secondary outcome measure we will look for changes in scores on the Spence Children's Anxiety Scale (SCAS).
The SCAS child-report is a 45 item questionnaire and the SCAS Parent-Report is a 39 item questionnaires with 4-point Likert scale responses.
Both forms assess six domains of anxiety including generalized anxiety, panic/agoraphobia, social phobia, separation anxiety, obsessive compulsive disorder and physical injury fears.
|
intake, end of baseline, end of treatment and exit (up to 4 times over approximately 20 weeks from intake to exit)
|
|
Modified Khalfa Hyperacusis Questionnaire
Time Frame: intake, end of baseline, end of treatment and exit (up to 4 times over approximately 20 weeks from intake to exit)
|
As an exploratory secondary outcome measure we will look for changes in scores on the Modified Khalfa Hyperacusis Questionnaire, a brief 20 item (3-point Likert scale) questionnaire to screen for auditory hypersensitivity (hyper-acusis).
|
intake, end of baseline, end of treatment and exit (up to 4 times over approximately 20 weeks from intake to exit)
|
|
Autism Symptoms
Time Frame: intake (week 1) and exit (final session approximately 20 weeks after intake)
|
As an exploratory secondary outcome measure we will look for changes in scores on the Autism Diagnostic Observation Schedule - 2 (ADOS-2) and the Autism Spectrum Rating Scales (ASRS).
The ADOS-2 is a play-based assessment that provides direct observation of the child's behavior and the ASRS is a norm-referenced, 71 item Likert scale parent questionnaire that identifies symptoms and behaviors across the autism spectrum.
|
intake (week 1) and exit (final session approximately 20 weeks after intake)
|
|
Sensory Profile
Time Frame: intake, end of baseline, end of treatment and exit (up to 4 times over approximately 20 weeks from intake to exit)
|
As an exploratory secondary outcome measure we will look for changes in scores on the Sensory Profile-2.
The Sensory Profile is an 86 item (5-point Likert scale) parent questionnaire (age 3-14) or Adolescent/adult questionnaire (ages 15 and above) that is used to evaluate how sensory processing and behaviors in a child compare to peers; norm-referenced on the following sensory sections: auditory, visual, touch, movement, body position, oral; behavioral sections: conduct, social/emotional and attention; as well as the following quadrants: seeking, avoiding, sensitivity and registration.
|
intake, end of baseline, end of treatment and exit (up to 4 times over approximately 20 weeks from intake to exit)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Tana Carson, PhD, Adjunct Associate Research Professor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 30, 2017
Primary Completion (Actual)
May 31, 2019
Study Completion (Actual)
May 31, 2019
Study Registration Dates
First Submitted
June 26, 2017
First Submitted That Met QC Criteria
June 30, 2017
First Posted (Actual)
July 2, 2017
Study Record Updates
Last Update Posted (Actual)
June 18, 2019
Last Update Submitted That Met QC Criteria
June 14, 2019
Last Verified
June 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB201601664
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Istituto Clinico HumanitasRecruitingAutism | Autism Spectrum Disorder (ASD) | Autism DisorderItaly
-
The Children's Hospital of Zhejiang University...Not yet recruitingAutism | Autism Spectrum Disorder (ASD)China
-
Poznan University of Physical EducationCompletedAutism | Autism Spectrum Disorder (ASD)Poland
-
Adia Med of Winter Park LLCActive, not recruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Poznan University of Physical EducationNational Science Centre, PolandCompletedAutism Spectrum Disorder | ASD | Autism Spectrum Disorder High-Functioning | Autism SpectrumPoland
-
Stanford UniversityJohn and Marcia Goldman FoundationNot yet recruitingAutism | Autism Spectrum Disorder (ASD)United States
-
Blinklab LimitedRecruitingAutism Spectrum Disorder | Autism | Neurodevelopmental Conditions | Autism Spectrum Disorder (ASD)United States
-
National Cheng-Kung University HospitalCompletedAutism Spectrum Disorder (ASD) | Autism Spectrum Disorder High-FunctioningTaiwan
-
University of California, Los AngelesUniversity of WashingtonRecruitingAutism Spectrum Disorder (ASD)United States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingAutism Spectrum Disorder (ASDFrance
Clinical Trials on Exposure therapy
-
Emory UniversityCenters for Disease Control and PreventionWithdrawnPost Traumatic Stress Disorder, PTSD
-
University of LouisvilleCompletedAnorexia Nervosa | Bulimia Nervosa | Eating Disorder | ExposureUnited States
-
University of LouisvilleCompletedAnorexia Nervosa | Binge-Eating Disorder | Bulimia Nervosa | Therapy | Eating Disorder | ExposureUnited States
-
Universidad de GranadaUnknown
-
Palo Alto Veterans Institute for ResearchCompletedWritten Exposure Therapy | Imaginal Exposure TherapyUnited States
-
University of Texas at AustinNational Institute of Mental Health (NIMH)CompletedSpecific PhobiaUnited States
-
Georgia State UniversityVirtually Better, Inc.CompletedSocial Anxiety DisorderUnited States
-
Universitätsklinikum Hamburg-EppendorfUnknownObsessive-compulsive Disorder (OCD)Germany
-
Emory UniversityCompleted
-
Luxembourg Institute of HealthCentre Hospitalier du LuxembourgCompleted